Global license provides American Regent, a wholly owned subsidiary of Daiichi Sankyo, with rights to commercialize Synoglide™ ...

Orthotics and exercise outperform medication: simple therapies offer greater relief for knee osteoarthritis with fewer risks.

An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee ...

Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Lenivia® ...

Dr. Anderson said the treatment uses low doses of radiation to target inflamed joints. Dr. Anderson also said the ratiation reduces the activity of inflammatory cells and calms the body’s immune ...

On August 18, 2025, Enlivex announced the 3-month topline data, reporting that Allocetra™ demonstrated, in the primary age group (60+), substantial reduction in pain and improvement in function across ...

One gram of fish oil a day could help reduce the pain of patients with osteoarthritis, a new study finds. Researchers also found that a reduction of weight for overweight and obese patients and the ...

New York, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Distribution ...

Alone or in combination, the supplements do not reduce joint pain or limit joint-space narrowing. Randomized trials on the effectiveness of glucosamine and chondroitin for osteoarthritis (OA) have ...

KeyBanc initiates Zoetis at Sector Weight, citing OA drug headwinds, rising competition, and limited near-term catalysts ...